Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-22-000067
Filing Date
2022-11-18
Accepted
2022-11-18 17:00:15
Documents
1
Effectiveness Date
2022-11-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11050
  Complete submission text file 0001231919-22-000067.txt   12462
Mailing Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-465372 | Film No.: 221402613
SIC: 2834 Pharmaceutical Preparations